RIPK1 inhibition in malignant cells potentiates immunotherapy and radiotherapy outcome

Apoptosis, necroptosis and pro-inflammatory NF-κB-dependent signaling are repressed by receptor-interacting serine/threonine-protein kinase 1 (RIPK1). A recent paper in Immunity describes a small molecule inducing the proteolytic degradation of RIPK1. In preclinical experiments, this RIPK1 inhibitor...

Full description

Bibliographic Details
Published in:	OncoImmunology
Main Authors:	Jonathan G. Pol, Andrea Checcoli, Manuela Lizarralde-Guerrero, Guido Kroemer
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Subjects:	Cancer immunotherapy immune checkpoint inhibitor immunogenic cell death necroptosis radiotherapy
Online Access:	https://www.tandfonline.com/doi/10.1080/2162402X.2024.2425465

Similar Items

Elimination of cDC1 cells by regulatory T cells jeopardizes cancer immunotherapy
by: Peng Liu, et al.
Published: (2024-12-01)

Targeted opening of the blood–brain barrier facilitates doxorubicin/anti-PD-1-based chemoimmunotherapy of glioblastoma
by: Jonathan G. Pol, et al.
Published: (2024-12-01)

Enhancing the efficacy of immunotherapy using radiotherapy
by: Synat Keam, et al.
Published: (2020-01-01)

Immunogenic oncolysis by tigilanol tiglate
by: Jonathan G. Pol, et al.
Published: (2024-12-01)

Radiotherapy and immunotherapy
by: Ewa Sierko
Published: (2023-02-01)

Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers
by: Vanessa Acebes-Fernández, et al.
Published: (2020-06-01)

Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimization
by: Greeshma Rajeev-Kumar, et al.
Published: (2023-02-01)

Combination of immunotherapy-radiotherapy in non-small cell lung cancer: Reality and perspective
by: Bouchra Amaoui, et al.
Published: (2021-12-01)

Mechanistic rationales for combining immunotherapy with radiotherapy
by: Alexander Chi, et al.
Published: (2023-06-01)

Anti-Proliferative Effect of Radiotherapy and Implication of Immunotherapy in Anaplastic Thyroid Cancer Cells
by: Sabine Wächter, et al.
Published: (2023-06-01)

Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors
by: Yuze Wu, et al.
Published: (2024-07-01)

Synergies between radiotherapy and immunotherapy: a systematic review from mechanism to clinical application
by: JingLong Jiang, et al.
Published: (2025-08-01)

Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better
by: Jayalakshmi Thiruppathi, et al.
Published: (2024-04-01)

The role of T cells in tumor radiotherapy combined with immunotherapy and gastrointestinal adverse events
by: SHI Xiaolin, et al.
Published: (2021-02-01)

Immunogenic chemotherapy sensitizes RAS-mutated colorectal cancers to immune checkpoint inhibitors
by: Lucillia Bezu, et al.
Published: (2023-12-01)

Dying of Stress: Chemotherapy, Radiotherapy, and Small-Molecule Inhibitors in Immunogenic Cell Death and Immunogenic Modulation
by: Kellsye P. Fabian, et al.
Published: (2022-11-01)

The grand challenges to cellular and molecular oncology
by: Lorenzo eGalluzzi, et al.
Published: (2011-03-01)

Gasdermin E links tumor cell-intrinsic nucleic acid signaling to proinflammatory cell death for successful checkpoint inhibitor cancer immunotherapy
by: Stefan Enssle, et al.
Published: (2025-12-01)

Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference
by: Pierre-Antoine Laurent, et al.
Published: (2025-12-01)

Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges
by: Jing Jin, et al.
Published: (2020-05-01)

Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions
by: Yifan Wang, et al.
Published: (2018-03-01)

Immunogenic Cell Death Role in Urothelial Cancer Therapy
by: Reza Yadollahvandmiandoab, et al.
Published: (2022-09-01)

Radiotherapy combined with anti-CEACAM1 immunotherapy to induce survival advantage in glioma
by: Jinhu Li, et al.
Published: (2023-03-01)

Radiotherapy in patients with brain metastases with and without concomitant immunotherapy: comparison of patient outcome and neurotoxicity
by: Natalie Elyan, et al.
Published: (2024-11-01)

Improving the efficacy of combined radiotherapy and immunotherapy: focusing on the effects of radiosensitivity
by: Zhiru Gao, et al.
Published: (2023-05-01)

Radiochemotherapy-induced elevations of plasma HMGB1 levels predict therapeutic responses in cancer patients
by: Guido Kroemer, et al.
Published: (2021-01-01)

Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop
by: Ariel E. Marciscano, et al.
Published: (2018-01-01)

Establishment of whole tumor cell antigen-induced cellular immunotherapy for lung adenocarcinoma
by: Zhu Binghan, et al.
Published: (2025-06-01)

Research progress in restrained immunotherapy efficacy for melanoma with liver metastasis and its countermeasures
by: Le HAN, et al.
Published: (2022-02-01)

Tumor lysis with LTX-401 creates anticancer immunity
by: Wei Xie, et al.
Published: (2019-07-01)

Mathematical Models of Death Signaling Networks
by: Madhumita Srinivasan, et al.
Published: (2022-10-01)

AIEgen-self-assembled nanoparticles with anti-PD-L1 antibody functionalization realize enhanced synergistic photodynamic therapy and immunotherapy against malignant melanoma
by: Lu Li, et al.
Published: (2025-02-01)

A mitochondrial checkpoint to adaptive anticancer immunity
by: Oliver Kepp, et al.
Published: (2023-12-01)

Necroptosis-driven T cell activation promotes IL-6-mediated PD-L1 upregulation in cholangiocarcinoma cells: IL-6 gene signature as a biomarker for chemo-immunotherapy response
by: Thanpisit Lomphithak, et al.
Published: (2025-09-01)

Immunogenic cell death mediation patterns reveal novel paradigm for characterizing the immune microenvironment and immunotherapeutic responses in bladder cancer
by: Jialei Fu, et al.
Published: (2022-10-01)

Physical parameters and biological factors affect the abscopal effect of combining radiotherapy with immunotherapy: an update on preclinical works
by: Wangcai Ren, et al.
Published: (2025-01-01)

Is the Combination of Immunotherapy and Radiotherapy in Non-small Cell Lung Cancer a Feasible and Effective Approach?
by: Mathieu Spaas, et al.
Published: (2019-11-01)

RIPK1 and RIPK3 are positive prognosticators for cervical cancer patients and C2 ceramide can inhibit tumor cell proliferation in vitro
by: Tilman L. R. Vogelsang, et al.
Published: (2023-05-01)

Corrigendum: Physical parameters and biological factors affect the abscopal effect of combining radiotherapy with immunotherapy: an update on preclinical works
by: Wangcai Ren, et al.
Published: (2025-01-01)

The Impact of RIPK1 Kinase Inhibition on Atherogenesis: A Genetic and a Pharmacological Approach
by: Pauline Puylaert, et al.
Published: (2022-04-01)